Kamada (KMDA) Profit After Tax (2012 - 2026)
Kamada's (KMDA) quarterly Profit After Tax came in at $4.1 million in Q1 2026, up 4.24% YoY from $4.0 million in Q1 2025, and up 16.0% on a QoQ basis from $3.6 million in Q4 2025.
Kamada (KMDA) Profit After Tax (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Profit After Tax data on file, last reported at $4.1 million in Q1 2026.
- Quarterly Profit After Tax rose 4.24% year-over-year to $4.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.0 million (up 11.67% YoY) and the FY2025 annual result came in at $20.2 million, up 39.66% from the prior year.
- Profit After Tax advanced to $4.1 million in Q1 2026, from $3.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $5.3 million in Q3 2025 to a low of -$3.9 million in Q2 2022.
- A 5-year average of $2.0 million and a median of $2.9 million in 2022 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 518.46% — and 2023, when it soared 665809.09%.
- Tracing KMDA's Profit After Tax over 5 years: stood at $2.9 million in 2022, then jumped by 71.81% to $5.1 million in 2023, then dropped by 24.71% to $3.8 million in 2024, then retreated by 6.46% to $3.6 million in 2025, then increased by 16.0% to $4.1 million in 2026.
- The last three Profit After Tax figures came in at $4.1 million (Q1 2026), $3.6 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kamada | 457.71 Mn | 428.24 Mn | 22.47 Mn | 9.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.26 Mn |
| Mar 31, 2026 | 4.13 Mn |
| Dec 31, 2025 | 3.56 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 7,376.00 |
| Mar 31, 2025 | 3.96 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 3.86 Mn |
| Jun 30, 2024 | 4,426.00 |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | -1,809.00 |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 484.00 |
| Jun 30, 2022 | -3.92 Mn |
| Mar 31, 2022 | -1.83 Mn |
| Dec 31, 2021 | -5.01 Mn |
| Sep 30, 2021 | -845,000.00 |